The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...
Medical Device Network on MSN
Abbott touts neuromodulation portfolio’s long-term benefits
Abbott’s five-year data highlighted neuromodulation therapies’ role in reducing healthcare and patient burdens associated ...
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...
This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...
Magnus Medical, Inc., the company behind SAINT®, the first and only FDA-cleared, rapid-remission therapy for Major Depressive Disorder (MDD), today announced that the Centers for Medicare & Medicaid ...
PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...
The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of ...
Boston Scientific (NYSE:BSX) has completed the acquisition of Nalu Medical, expanding its presence in chronic pain treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results